Comparison of Total Arch and Partial Arch Transposition During Hybrid Endovascular Repair for Aortic Arch Disease
- Authors
- Kang, W. C.; Ko, Y. -G.; Oh, P. C.; Shin, E. K.; Park, C. -H.; Choi, D.; Youn, Y. N.; Lee, D. Y.
- Issue Date
- Aug-2016
- Publisher
- W B SAUNDERS CO LTD
- Keywords
- Hybrid endovascular repair; Total arch transposition; Partial arch transposition; Stent graft; Mortality; Re-intervention
- Citation
- EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, v.52, no.2, pp.173 - 178
- Journal Title
- EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Volume
- 52
- Number
- 2
- Start Page
- 173
- End Page
- 178
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8051
- DOI
- 10.1016/j.ejvs.2016.06.001
- ISSN
- 1078-5884
- Abstract
- Objective: Total arch transposition (TAT) during hybrid endovascular repair for aortic arch disease is believed to allow a better landing zone, but also to be associated with higher peri-operative mortality than partial arch transposition (PAT). Information on this issue is limited. Method: This study was a retrospective analysis. All 53 consecutive patients with aortic arch disease (41 males, mean age 65.0 years) who underwent hybrid endovascular repair with TAT (zone 0, n=20) or PAT (zone 1 or 2, n=33) from 2008 to 2014 were analyzed retrospectively. The peri-operative and late outcomes of these two groups were compared. Results: Baseline characteristics, including EuroSCORE II results, were similar in the two groups. After procedures, peri-operative mortalities and stroke rates were similar in the two groups (5.0% vs. 9.1%, p=1.000, and 10.0% vs. 6.1%, p=.627). Interestingly, all four strokes occurred in patients with a type III aortic arch irrespective of transposition type. Primary success rates (80.0% vs. 69.7%, p=.527) and type I endoleak incidences (20.0% vs. 27.3%, p=.744) were not significantly different. During follow up (mean duration 36.9 months), overall survival (89.7% vs. 87.4% at 1 year and 89.7% vs. 79.3% at 3 years; p=.375) and re-intervention free survival rates (78.6% vs. 92.0% at 1 year; 72.0% vs. 62.2% at 3 years, p=.872) were similar in the two groups. Conclusion: Morbidity and mortality were high within the first year of hybrid endovascular therapy for aortic arch disease, implying that candidates for hybrid procedures need to be selected carefully. Hybrid endovascular repair with TAT-was found to have peri-operative mortality, stroke, and long-term survival rates comparable with PAT, so hybrid endovascular repair may be considered, irrespective of type of arch reconstruction, when clinically indicated. (C) 2016 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
- 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8051)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.